Vivos Therapeutics (VVOS) Asset Utilization Ratio (2021 - 2026)
Vivos Therapeutics (VVOS) reported Asset Utilization Ratio of 0.78 for Q1 2026, down 29.2% year-over-year from 1.1 in Q1 2025, and up 13.53% on a QoQ basis from 0.69 in Q4 2025.
Vivos Therapeutics (VVOS) has 6 years of Asset Utilization Ratio data on file, last reported at 0.78 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 29.2% year-over-year to 0.78 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.78 (down 29.2% YoY) and the FY2025 annual result came in at 0.86, down 25.34% from the prior year.
- Asset Utilization Ratio climbed to 0.78 in Q1 2026 per VVOS's latest filing, from 0.69 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.31 in Q4 2023 and bottomed at 0.54 in Q1 2022.
- The 5-year median for Asset Utilization Ratio is 0.98 (2024), against an average of 0.92.
- The widest annual swing landed in 2022, when Asset Utilization Ratio jumped 120.75%; it then plunged 30.02% in 2025.
- Tracing VVOS's Asset Utilization Ratio over 5 years: stood at 1.0 in 2022, then jumped by 31.44% to 1.31 in 2023, then fell by 25.16% to 0.98 in 2024, then sank by 30.02% to 0.69 in 2025, then advanced by 13.53% to 0.78 in 2026.
- Per Business Quant, the three latest VVOS Asset Utilization Ratio figures stand at 0.78 (Q1 2026), 0.69 (Q4 2025), and 0.67 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.39 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.47 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.65 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.74 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.57 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.56 |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | 0.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.78 |
| Dec 31, 2025 | 0.69 |
| Sep 30, 2025 | 0.67 |
| Jun 30, 2025 | 0.77 |
| Mar 31, 2025 | 1.10 |
| Dec 31, 2024 | 0.98 |
| Sep 30, 2024 | 0.94 |
| Jun 30, 2024 | 1.01 |
| Mar 31, 2024 | 1.19 |
| Dec 31, 2023 | 1.31 |
| Sep 30, 2023 | 1.21 |
| Jun 30, 2023 | 1.00 |
| Mar 31, 2023 | 1.05 |
| Dec 31, 2022 | 1.00 |
| Sep 30, 2022 | 0.77 |
| Jun 30, 2022 | 0.62 |
| Mar 31, 2022 | 0.54 |
| Dec 31, 2021 | 0.45 |
| Sep 30, 2021 | 0.36 |
| Jun 30, 2021 | 0.43 |
| Mar 31, 2021 | 0.56 |